Pacer Advisors, Inc. Iovance Biotherapeutics, Inc. Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.78 - $14.19 $8,674 - $15,821	1,115 Added 41.05%	3,831 $30,000
Q1 2024 May 10, 2024	BUY	$7.59 - $17.47 $20,614 - $47,448	2,716 New	2,716 $40,000
Q2 2021 Jul 21, 2021	SELL	$16.33 - $33.07 $35,713 - $72,324	-2,187 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$28.67 - $52.59 $13,130 - $24,086	-458 Reduced 17.32%	2,187 $69,000
Q4 2020 Jan 20, 2021	SELL	$28.04 - $50.26 $25,684 - $46,038	-916 Reduced 25.72%	2,645 $123,000
Q3 2020 Oct 19, 2020	BUY	$27.75 - $36.3 $98,817 - $129,264	3,561 New	3,561 $117,000
Q4 2018 Feb 13, 2019	SELL	$7.51 - $11.93 $65,081 - $103,385	-8,666 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $97,492 - $153,388	8,666 New	8,666 $97,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.46B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.